Moneycontrol
you are here: HomeNewsIndia
Last Updated : Jun 24, 2020 09:21 PM IST | Source: Moneycontrol.com

Patanjali launches Coronil: AYUSH Ministry asks Baba Ramdev-led company to stop advertising drug till it's examined

The firm claimed that two medicines, Coronil and Swasari, have shown 100 percent favourable results during clinical trials on COVID-19 infected patients, except those on life support system

The AYUSH Ministry has directed Patanjali Ayurved to stop advertising or publicising claims related to their new coronavirus medicine till the issue is duly examined.

Taking cognizance of Patanjali launching an Ayurvedic medicine, which the company claims can treat COVID-19 in seven days, the AYUSH Ministry said the facts of the claim as well as details of the scientific study are not known to the ministry.

Close

Yoga guru Ramdev's herbal medicine company on June 23 claimed to have discovered a cure for coronavirus in two Ayurved-based medicines – Coronil and Swasari – curing the highly contagious disease within seven days.

The firm claimed that the two medicines have shown 100 percent favourable results during clinical trials on COVID-19 infected patients, except those on life support system.

Citing the provisions under Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954, as well as the directives issued by the Centre in the wake of the novel coronavirus outbreak, the AYUSH Ministry asked Patanjali Ayurved to provide the details of the name and composition of the medicines "at the earliest".

The ministry also asked Ramdev's firm to provide details of the site or hospital, where the research study was conducted for COVID-19; the protocol, sample size, Institutional Ethics Committee clearance, CTRI registration  and results data of the study.

The AYUSH Ministry has requested the concerned State Licensing Authority of Uttarakhand government to provide copies of the licence and product approval details of the Ayurvedic medicines being claimed for the treatment of COVID -19.

Soon after this, Patanjali Ayurved CEO Acharya Balkrishna gave a statement saying, "This government provides encouragement and pride to Ayurveda. Communication gap has been done away with and we have 100 percent fulfilled all standard parameters for Randomised Placebo-Controlled Clinical Trials. We've given the information for the same to AYUSH Ministry."
First Published on Jun 23, 2020 07:04 pm
Sections